Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies
14 July 2010
David Rosen will present, “Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies” at the ACI 7th National Forum on Off-Label Communications, July 14-15, 2010 at the Union League, in Philadelphia.
Speakers will cover compliance strategies with FDA off-label promotion guidelines, training physicians on the use of medical devices, and learning from device manufacturers’ litigation. Thomas Lynch, Senior Corporate Counsel at Boston Scientific will join Mr. Rosen as a speaker.
More information can be found on ACI’s Web site.
People
Related Insights
23 May 2025
Tariff & International Trade Resource
Oscar the Grouchy CCO
This Memorial Day marks 35 years since Jim Henson, creator of the Muppets, passed away. Among his many accomplishments, the Muppets were essential to the creation of the longest-running children’s television show, “Sesame Street,” which has been airing for over 55 years.
03 June 2025
Events
FO PRO: ALIGN: Connecting the Family and the Family Office
Foley partner, Nate Imfeld, and senior counsel, Nicholas Chamis, will be speaking at the upcoming ALIGN Conference, hosted by Family Business Magazine in Chicago, Illinois. They will be hosting the breakout session, Sports Teams, AI, Bitcoin and More.
04 June 2025
Events
Health Care Organizations: Reduce Cybersecurity Threats
Foley partner Jennifer Urban, chair of the firm’s Cybersecurity & Data Privacy Area of Focus, is speaking in Moss Adams’ upcoming webinar titled “Health Care Organizations: Reduce Cybersecurity Threats” on June 4.